Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, AutologousTransplantation, HomologousTransplantation ConditioningGraft vs Host DiseaseHematopoietic Stem Cell MobilizationStem Cell TransplantationHematologic NeoplasmsBone MarrowGranulocyte Colony-Stimulating FactorLeukapheresisGraft SurvivalMelphalanCombined Modality TherapyAntigens, CD34CyclophosphamideBusulfanHematopoietic Stem CellsTransplantation ChimeraBone Marrow CellsBlood Component RemovalWhole-Body IrradiationTissue DonorsTreatment OutcomeMultiple MyelomaRecurrenceAntineoplastic Combined Chemotherapy ProtocolsStem CellsMyeloablative AgonistsCord Blood Stem Cell TransplantationHistocompatibilityRemission InductionLeukemiaHistocompatibility TestingLymphoma, Non-HodgkinTransplantation, IsogeneicAnemia, AplasticEtoposideHematopoiesisLiver TransplantationImmunosuppressive AgentsAntineoplastic Agents, AlkylatingBlood CellsRetrospective StudiesDisease-Free SurvivalThiotepaLeukemia, Myeloid, AcuteInfectionTime FactorsSurvival AnalysisBone Marrow PurgingSurvival RatePOEMS SyndromeCarmustineLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Leukemia EffectCytarabineSalvage TherapyVidarabineMyelodysplastic SyndromesHodgkin DiseaseBone Marrow DiseasesLymphocyte DepletionVincristinePrecursor Cell Lymphoblastic Leukemia-LymphomaPlatelet CountCytomegalovirus InfectionsKidney TransplantationBlood Cell CountAmyloidosisLymphomaImmunosuppressionHematologic DiseasesIfosfamideHLA AntigensCyclosporineFollow-Up StudiesBone and BonesFatal OutcomeTransplantation ImmunologyOpportunistic InfectionsT-LymphocytesImmunophenotypingAcute DiseaseLeukocyte CountNeoplasmsHistiocytosis, Non-Langerhans-CellProspective StudiesLeukocyte TransfusionLymphocyte TransfusionRecombinant ProteinsNuclear FamilyGraft vs Tumor EffectPrognosisHepatic Veno-Occlusive DiseaseMesenchymal Stem Cell TransplantationFeasibility StudiesDoxorubicin